Author: BusinessWire

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021

European Commission has the option to request an additional 100 million doses

NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfize…

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News:

Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the fi…

OSLO, Norway–(BUSINESS WIRE)–$ULTI #4Q20–Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a pharmaceutical company developing novel immunotherapies against cancer, announces its fourth quarter 2021 results today. A presentation by the company’s managemen…

OSLO, Norway–(BUSINESS WIRE)–$ULTI #4Q20–Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a pharmaceutical company developing novel immunotherapies against cancer, announces its fourth quarter 2021 results today. A presentation by the company’s managemen…

 — Successful bought deal offering brings total capital raised to-date to approximately $90 million —

— Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines –

— Adelia …

SAN FRANCISCO–(BUSINESS WIRE)–#lifesciences–FS Development Corp. II (the “Company”) announced today that it priced its initial public offering of 17,500,000 shares of Class A common stock at $10.00 per share. The shares will be listed on The Nasdaq …

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 9, 2021.

Nikhil Lalwani, Presid…

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the closing of its previously announced upsized public offering of 6,181,250 shares of its common stock at a price to the publi…

Prominent Researcher Brings Pharmaceutical Product Development Expertise
AUSTIN, Texas–(BUSINESS WIRE)–Maxwell Biosciences develops antiviral drugs, designed to be Zero-Day Therapeutics (ZDT), which have been shown in preclinical studies to destroy …

DUBLIN–(BUSINESS WIRE)–The “AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

The “AI-based Drug Discovery Market: Focus on Machine Learning and Deep L…